RxDoctor Payments Data

Rachel West

Family Medicine · Santa Monica, CANPI 1215000237

Payments from drug & device makers

$1,258in general payments, 2019–2025

Across 73 payments — averaging $17.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$419
  • AbbVie$178
  • Romark Laboratories, LC$128
  • Merck$104
  • Boston Scientific$54
  • GSK$41
  • plus $333 from 16 others

What the payments were for

  • Consulting fees$242%
  • Food & beverage$1,23498%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,258 in reported general payments places this provider in the 75th percentile of 10,533 family medicine providers in California.

See all family medicine providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol (Twice Weekly)Estradiol23$1,359
Nystatin22$1,266
ValacyclovirValacyclovir Hcl23$804
SynthroidLevothyroxine Sodium13$604
Fluconazole25$532
Prednisone47$386
ProgesteroneProgesterone, Micronized11$285
Levothyroxine Sodium34$160
Hydrocortisone11$149
Metformin Hcl14$112
Bupropion Hcl SrBupropion Hcl11$83

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieSynthroid$178$60413 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 10,533 family medicine providers in California.

Other family medicine in Santa Monica

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →